BPA Levels Relationship With IVF/ICSI Outcomes in Unexplained Infertility

N/ACompletedNCT04472234

Nefise Nazlı YENIGUL82 enrolled

Overview

The relationship between BPA elevation in urine, blood, and follicle fluid and embryo quality, IVF/ICSI outcomes.

Study Type

INTERVENTIONAL

Allocation

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Infertility Unexplained IVF Infertility, Female

Interventions

BPA levelsOTHER

BPA (Bisfenol A) in urine, blood and follicle fluid samples

Eligibility

Sex: FEMALEMin age: 23 YearsMax age: 33 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * patients aged 23-33 years who underwent IVF due to unexplained infertility * patients provided urine, blood, and follicle fluid (FF) samples on the oocyte retrieval day * patients who did not smoke or use alcohol * patients did not work in the plastic industry Exclusion Criteria: * patients who underwent IVF due to low ovarian reserve or tubal factor or male factor indications * patients diagnosed with endometriosis * patients with freeze-all cycles * women with metabolic disease (such as hypertension or diabetes mellitus) * patients with a known genetic problem (male or female)

Locations (1)

Nefise Nazlı YENIGUL

Sanliurfa, Turkey (Türkiye)

Outcomes

Primary Outcomes

Exposure to BPA

Concentrations of Bisphenol A (BPA) will be quantified in the ürine, blood plasma, and follicular fluid (individual and pooled samples) by use of ELİSA test in women with unexplained infertility

Time frame: 6 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.